Design Therapeutics Inc
Company Profile
Business description
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company’s product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
Contact
6005 Hidden Valley Road
Suite 110
Carlsbad CA 92011
USAT: +1 858 293-4900
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
57
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,153.40 | 59.10 | 0.73% |
CAC 40 | 7,517.68 | 90.66 | 1.22% |
DAX 40 | 18,417.55 | 118.83 | 0.65% |
Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
FTSE 100 | 8,285.71 | 99.36 | 1.21% |
HKSE | 17,021.31 | 16.34 | 0.10% |
NASDAQ | 17,357.88 | 176.16 | 1.03% |
Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
S&P 500 | 5,459.10 | 59.88 | 1.11% |
S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |